Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Banzo, D Abós M, E. Prats, F. García, P. Razola.
La gammagrafía de receptores de somatostatina en el diagnóstico y estadificación de los tumores neuroendocrinos del aparato digestivo y páncreas.
Rev Esp Med Nuclear, 19 (2000), pp. 225-239
[2.]
J.C. Reubi.
Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.
J Nucl Med, 36 (1995), pp. 1825-1835
[3.]
M. Jhon, W. Meyerhof, D. Richter, B. Waser, J.C. Schaer, H. Scherübl, et al.
Positive somatostatin receptor scintigraphy correlated with the presence of somatostatin receptor subtype 2.
Gut, 38 (1996), pp. 33-39
[4.]
H. Yim, B.A. Siegel, M.K. DeBenedetti, J.A. Norton, T.C. Lairmore, G.M. Doherty.
Prospective study of the utility of somatostatinreceptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1.
Surgery, 124 (1998), pp. 1037-1042
[5.]
Y. Oda, Y. Tanaka, T. Naruse, R. Sasanabe, M. Tsubamoto, H. Funahashi.
Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors.
Surg Today, 32 (2002), pp. 690-694
[6.]
B.T. Teh, J. McArdle, V. Parameswaran, R. David, C. Larsson, J. Shepherd.
Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1.
Arch Surg, 131 (1996), pp. 1230
[7.]
L.J. Deftos, B.D. Catre, H.G. Bone III.
Multiglandular endocrine disorders.
Endocrinology and metabolism, pp. 1662-1691
[8.]
D. Trump, B. Farren, C. Wooding, J.T. Pang, G.M. Besser, K.D. Buchanan, et al.
Clinical studies of multiple endocrine neoplasia type 1 (MEN 1).
QJM, 89 (1996), pp. 653
[9.]
L.K. Kvols.
Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging and treatment of tumours.
Gastroenterology, 105 (1993), pp. 1909-1911
[10.]
Dop FJ. 111In-DTPA- octreotide receptor scintigraphy in GEP tumors: a comparation of trials. Uptodate 1:32-4
[11.]
G. Cadiot, R. Lebtahi, L. Sarda, G. Bonnaud, J.P. Marmuse, C. Visuzaine, et al.
Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigrphy.
Gastroenterology, 16 (1996), pp. 34-38
[12.]
Endocrine tumours of the pancreas: review and recent advances.
Aust NZJ Surg, 71 (2001), pp. 475-482
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
